511,215 CME Group Inc. $CME Shares Purchased by Eurizon Capital SGR S.p.A.

Key Points

• Eurizon Capital SGR increased its CME Group stake by 1,013.4%, buying 511,215 shares in the third quarter to hold 561,661 shares valued at about $147.4 million.
• CME Group beat quarterly earnings and revenue estimates, reporting EPS of $3.02 and revenue of $1.74 billion; revenue grew 10.6% year over year.
• The company declared a quarterly dividend of $1.30 per share, equivalent to a $5.20 annualized payout and a 1.6% yield.

Eurizon Capital SGR S.p.A. lifted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1,013.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 561,661 shares of the financial services provider's stock after purchasing an additional 511,215 shares during the period. Eurizon Capital SGR S.p.A. owned 0.16% of CME Group worth $147,407,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. BlackRock Inc. purchased a new position in CME Group during the 2nd quarter valued at about $6,749,965,000. Bank of America Corp DE raised its position in CME Group by 39.1% during the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider's stock valued at $1,187,290,000 after purchasing an additional 1,130,587 shares during the last quarter. Bank of New York Mellon Corp bought a new position in CME Group during the 2nd quarter valued at approximately $867,313,000. Alphabet Inc. bought a new position in CME Group during the 2nd quarter valued at approximately $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in CME Group in the 2nd quarter worth approximately $629,771,000. 87.75% of the stock is owned by institutional investors.

CME Group Trading Down 0.1%

Shares of CME opened at $315.50 on Friday. The firm's 50-day moving average price is $285.29 and its 200-day moving average price is $281.38. The firm has a market capitalization of $112.93 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 3.85 and a beta of 0.15. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.71 billion. During the same quarter in the previous year, the company earned $2.68 earnings per share. CME Group's quarterly revenue was up 10.6% on a year-over-year basis. Sell-side analysts anticipate that CME Group Inc. will post 12.35 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be issued a $1.30 dividend. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a yield of 1.6%. CME Group's dividend payout ratio (DPR) is 42.66%.

Insider Buying and Selling at CME Group

In other CME Group news, Director Howard J. Siegel sold 2,000 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the transaction, the director owned 19,873 shares in the company, valued at approximately $6,021,519. This represents a 9.14% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Julie Winkler sold 10,079 shares of the stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the transaction, the insider directly owned 21,482 shares of the company's stock, valued at $6,555,232.30. This represents a 31.93% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 33,511 shares of company stock worth $9,714,580. Insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CME shares. JPMorgan Chase & Co. upgraded CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 price objective for the company in a report on Thursday, October 22nd. UBS Group boosted their target price on CME Group from $270.00 to $310.00 and gave the company a "neutral" rating in a research note on Thursday, October 22nd. Wells Fargo & Company upped their target price on CME Group from $315.00 to $333.00 and gave the company an "overweight" rating in a report on Thursday, October 22nd. Deutsche Bank downgraded CME Group from a "buy" rating to a "hold" rating and decreased their target price for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $330.00 price target (up from $295.00) on shares of CME Group in a research note on Thursday, October 22nd. Ten research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, CME Group presently has an average rating of "Hold" and an average price target of $314.44.

About CME Group

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.